IHT Wealth Management’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$867K Sell
17,555
-3,126
-15% -$159K 0.02% 645
2026
Q1
$1.1M Sell
20,681
-340
-2% -$20K 0.03% 539
2025
Q4
$1.31M Sell
21,021
-3,631
-15% -$224K 0.03% 461
2025
Q3
$1.48M Buy
24,652
+1,477
+6% +$90.3K 0.04% 414
2025
Q2
$1.45M Sell
23,175
-1,213
-5% -$72.9K 0.04% 388
2025
Q1
$1.47M Sell
24,388
-3,360
-12% -$209K 0.05% 358
2024
Q4
$1.62M Sell
27,748
-4,250
-13% -$253K 0.05% 318
2024
Q3
$1.89M Buy
31,998
+1,895
+6% +$108K 0.05% 337
2024
Q2
$1.69M Sell
30,103
-5,048
-14% -$283K 0.06% 289
2024
Q1
$2.06M Buy
35,151
+11,084
+46% +$626K 0.08% 243
2023
Q4
$1.3M Sell
24,067
-5,538
-19% -$271K 0.06% 318
2023
Q3
$1.44M Sell
29,605
-22
-0.1% -$1.17K 0.07% 261
2023
Q2
$1.67M Sell
29,627
-2,023
-6% -$111K 0.09% 217
2023
Q1
$1.71M Sell
31,650
-363
-1% -$19.3K 0.1% 205
2022
Q4
$1.68M Sell
32,013
-1,597
-5% -$81K 0.11% 204
2022
Q3
$1.59M Buy
33,610
+3,214
+11% +$167K 0.12% 196
2022
Q2
$1.53M Sell
30,396
-2,417
-7% -$132K 0.14% 163
2022
Q1
$2M Sell
32,813
-3,758
-10% -$224K 0.15% 141
2021
Q4
$2.41M Sell
36,571
-3,298
-8% -$211K 0.18% 121
2021
Q3
$2.5M Buy
39,869
+6,035
+18% +$385K 0.2% 108
2021
Q2
$2.04M Buy
33,834
+2,124
+7% +$123K 0.13% 165
2021
Q1
$1.75M Sell
31,710
-1,086
-3% -$60.2K 0.13% 169
2020
Q4
$1.79M Buy
32,796
+1,524
+5% +$79.7K 0.15% 146
2020
Q3
$1.56M Buy
31,272
+2,700
+9% +$131K 0.16% 138
2020
Q2
$1.26M Buy
28,572
+522
+2% +$22.3K 0.17% 134
2020
Q1
$1.05M Buy
28,050
+21,492
+328% +$905K 0.15% 156
2019
Q4
$289K Buy
+6,558
New +$276K 0.03% 453
2018
Q2
Sell
-1,266
Closed -$38K 870
2018
Q1
$38K Buy
1,266
+60
+5% +$1.85K 0.01% 765
2017
Q4
$36K Hold
1,206
0.01% 794
2017
Q3
$34K Buy
1,206
+552
+84% +$15.3K 0.01% 623
2017
Q2
$53K Buy
+654
New +$17.3K 0.03% 489

Other funds holding IHI

IHT Wealth Management's IHI Position: Q2 2026 in Review

IHT Wealth Management reduced its iShares US Medical Devices ETF (IHI) stake by 15% in Q2 2026, selling an estimated $159K and leaving 17,555 shares worth $867K. The position accounts for 0.02% of the portfolio, ranked #645.

IHT Wealth Management first reported a position in IHI in Q2 2017 and has held it in 31 quarters since. The position peaked at $2.5M in Q3 2021. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • IHT Wealth Management held 17,555 shares of iShares US Medical Devices ETF worth $867K as of Q2 2026.
  • IHT Wealth Management sold 3,126 iShares US Medical Devices ETF shares in Q2 2026, an estimated $159K.
  • iShares US Medical Devices ETF made up 0.02% of IHT Wealth Management's portfolio in Q2 2026, its #645 holding.
  • IHT Wealth Management first reported a position in iShares US Medical Devices ETF in Q2 2017 and has held it in 31 quarters since.
  • IHT Wealth Management's iShares US Medical Devices ETF position peaked at $2.5M in Q3 2021.
  • 501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on IHT Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.